Inventor · disambiguated record
Penelope Andreux
Also filed as: ANDREUX PENELOPE
30 granted patents·12 pending applications·210 citations·filing 2011–2025
97Inventor score
Top patents by PatentIndex Score
42 records- 0198US12297182B2Compositions comprising an urolithin compoundAMAZENTIS SA·Filed 2024·Granted May 13, 2025·4 cites·17 claims
- 0298US11878964B2Compositions comprising an urolithin compoundAMAZENTIS SA·Filed 2021·Granted Jan 23, 2024·4 cites·21 claims
- 0397US12036205B2Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disordersAMAZENTIS SA·Filed 2022·Granted Jul 16, 2024·4 cites·21 claims
- 0497US11337957B2Compositions comprising urolithin compoundsAMAZENTIS SA·Filed 2020·Granted May 24, 2022·6 cites·17 claims
- 0597US11166937B2Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disordersAMAZENTIS SA·Filed 2018·Granted Nov 9, 2021·10 cites·18 claims
- 0697US10988453B2Compositions comprising an urolithin compoundAMAZENTIS SA·Filed 2019·Granted Apr 27, 2021·12 cites·21 claims
- 0796US12310943B2Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disordersAMAZENTIS SA·Filed 2023·Granted May 27, 2025·3 cites·35 claims
- 0896US11925616B2Compositions comprising urolithin compoundsAMAZENTIS SA·Filed 2022·Granted Mar 12, 2024·3 cites·8 claims
- 0996US11903922B2Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disordersAMAZENTIS SA·Filed 2020·Granted Feb 20, 2024·4 cites·20 claims
- 1096US11234960B2Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disordersAMAZENTIS SA·Filed 2015·Granted Feb 1, 2022·10 cites·21 claims
- 1196US11166972B2Compositions comprising nicotinamide riboside and a urolithinAMAZENTIS SA·Filed 2016·Granted Nov 9, 2021·13 cites·15 claims
- 1296US10857126B2Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disordersAMAZENTIS SA·Filed 2016·Granted Dec 8, 2020·12 cites·19 claims
- 1396US10442784B2Compositions comprising an urolithin compoundAMAZENTIS SA·Filed 2016·Granted Oct 15, 2019·11 cites·19 claims
- 1495US12220424B2Compositions comprising nicotinamide riboside and a urolithinAMAZENTIS SA·Filed 2021·Granted Feb 11, 2025·3 cites·10 claims
- 1595US11931336B2Enhancing autophagy or increasing longevity by administration of urolithinsAMAZENTIS SA·Filed 2021·Granted Mar 19, 2024·4 cites·20 claims
- 1695US10485782B2Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disordersAMAZENTIS SA·Filed 2016·Granted Nov 26, 2019·14 cites·33 claims
- 1794US12109190B2Urolithins as immune response enhancersAMAZENTIS SA·Filed 2022·Granted Oct 8, 2024·3 cites·20 claims
- 1894US11931335B2Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereofAMAZENTIS SA·Filed 2020·Granted Mar 19, 2024·3 cites·30 claims
- 1994US10695320B2Compositions comprising urolithin compoundsAMAZENTIS SA·Filed 2016·Granted Jun 30, 2020·13 cites·9 claims
- 2094US10028932B2Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disordersAMAZENTIS SA·Filed 2015·Granted Jul 24, 2018·13 cites·40 claims
- 2194US9962366B2Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereofAMAZENTIS SA·Filed 2015·Granted May 8, 2018·13 cites·20 claims
- 2293US11820751B2Urolithin derivatives and methods of use thereofVANDRIA SA·Filed 2022·Granted Nov 21, 2023·3 cites·6 claims
- 2393US11426380B2Urolithins as immune response enhancersAMAZENTIS SA·Filed 2020·Granted Aug 30, 2022·4 cites·20 claims
- 2493US10792276B2Urolithins as immune response enhancersAMAZENTIS SA·Filed 2019·Granted Oct 6, 2020·9 cites·19 claims
- 2593US9872850B2Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disordersRINSCH CHRISTOPHER LAWRENCE·Filed 2011·Granted Jan 23, 2018·18 cites·46 claims
- 2691US11020373B2Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereofAMAZENTIS SA·Filed 2013·Granted Jun 1, 2021·11 cites·20 claims
- 2790US2025375415A1Enhancing autophagy or increasing longevity by administration of urolithinsAMAZENTIS SA·Filed 2025·Application pending·0 cites
- 2889US2024156777A1Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disordersAMAZENTIS SA·Filed 2024·Application pending·0 cites
- 2988US11969408B2Method for improving mitophagy in subjectsAMAZENTIS SA·Filed 2018·Granted Apr 30, 2024·3 cites·19 claims
- 3084US12473269B2Urolithin derivatives and methods of use thereofVANDRIA SA·Filed 2023·Granted Nov 18, 2025·0 cites·12 claims
- 3184US2023390238A1Enhancing autophagy or increasing longevity by administration of urolithinsAMAZENTIS SA·Filed 2023·Application pending·0 cites
- 3283US12358884B2Urolithin derivatives and methods of use thereofVANDRIA SA·Filed 2023·Granted Jul 15, 2025·0 cites·20 claims
- 3382US12351567B2Urolithin derivatives and methods of use thereofVANDRIA SA·Filed 2023·Granted Jul 8, 2025·0 cites·19 claims
- 3481US2024148690A1Compositions comprising urolithin compoundsAMAZENTIS SA·Filed 2024·Application pending·0 cites
- 3572US2025381118A1Skin treatment methodsAMAZENTIS SA·Filed 2025·Application pending·0 cites
- 3666US2021251869A1Skin treatment methodsAMAZENTIS SA·Filed 2020·Application pending·0 cites
- 3764US2024424006A1Use of urolithin derivatives in the treatment of amyotrophic lateral sclerosisVANDRIA SA·Filed 2024·Application pending·0 cites
- 3864US2018015069A1Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereofAMAZENTIS SA·Filed 2017·Application pending·0 cites
- 3964US2018256471A1Skin Treatment MethodsAMAZENTIS SA·Filed 2018·Application pending·0 cites
- 4062US2024051933A1Urolithin derivatives and therapeutic usesVANDRIA SA·Filed 2023·Application pending·0 cites
- 4162US2024139149A1Therapeutic uses of urolithin derivativesVANDRIA SA·Filed 2023·Application pending·0 cites
- 4248US2018256538A1Method for improving mitophagy in subjectsAMAZENTIS SA·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Penelope Andreux files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →